The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients

Dalziza Victalina de Almeida; Priscila Alves Cezar; Thais Freitas Barreto Fernandes; Marcos Gustavo Araujo Schwarz; Leila Mendonça-Lima; Carmem Beatriz Wagner Giacoia-Gripp; Fernanda Heloise Côrtes; Monick Lindenmeyer Guimarães; Jose Henrique Pilotto; Nathalia Beatriz Ramos de Sá; Andressa da Silva Cazote; Larissa Rodrigues Gomes; Marcel de Souza Borges Quintana; Marcelo Ribeiro-Alves; Lara Coelho; Kim Mattos Geraldo; Maria Pia Diniz Ribeiro; Sandra Wagner Cardoso; Beatriz Gilda Jegerhom Grinsztejn; Valdiléa Gonçalves Veloso dos Santos; Mariza Gonçalves Morgado

doi:10.1101/2023.03.02.23286693

The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients

Dalziza Victalina de Almeida, Priscila Alves Cezar, Thais Freitas Barreto Fernandes, Marcos Gustavo Araujo Schwarz, Leila Mendonça-Lima, Carmem Beatriz Wagner Giacoia-Gripp, Fernanda Heloise Côrtes, Monick Lindenmeyer Guimarães, Jose Henrique Pilotto, Nathalia Beatriz Ramos de Sá, Andressa da Silva Cazote, Larissa Rodrigues Gomes, Marcel de Souza Borges Quintana, Marcelo Ribeiro-Alves, Lara Coelho, Kim Mattos Geraldo, Maria Pia Diniz Ribeiro, Sandra Wagner Cardoso, Beatriz Gilda Jegerhom Grinsztejn, Valdiléa Gonçalves Veloso dos Santos, Mariza Gonçalves Morgado

doi: https://doi.org/10.1101/2023.03.02.23286693

Now published in Microbiology Spectrum doi: 10.1128/spectrum.00959-23

Dalziza Victalina de Almeida

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: dalziza@gmail.com

Priscila Alves Cezar

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thais Freitas Barreto Fernandes

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcos Gustavo Araujo Schwarz

2Laboratory of Functional Genomics and Bioinformatics, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leila Mendonça-Lima

2Laboratory of Functional Genomics and Bioinformatics, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carmem Beatriz Wagner Giacoia-Gripp

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Fernanda Heloise Côrtes

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Monick Lindenmeyer Guimarães

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jose Henrique Pilotto

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nathalia Beatriz Ramos de Sá

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andressa da Silva Cazote

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Larissa Rodrigues Gomes

3Center of Technological Development in Health (CDTS)/National Institute of Science and Technological for Innovation on Neglected population diseases (INCT-IDPN), FIOCRUZ, Rio de Janeiro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcel de Souza Borges Quintana

4Clinical Research Platform, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, RJ, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcelo Ribeiro-Alves

5Laboratory of Clinical Research on STD/AIDS, National Institute of Infectology Evandro Chagas, FIO-CRUZ, Rio de Janeiro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lara Coelho

5Laboratory of Clinical Research on STD/AIDS, National Institute of Infectology Evandro Chagas, FIO-CRUZ, Rio de Janeiro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kim Mattos Geraldo

5Laboratory of Clinical Research on STD/AIDS, National Institute of Infectology Evandro Chagas, FIO-CRUZ, Rio de Janeiro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Pia Diniz Ribeiro

5Laboratory of Clinical Research on STD/AIDS, National Institute of Infectology Evandro Chagas, FIO-CRUZ, Rio de Janeiro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sandra Wagner Cardoso

5Laboratory of Clinical Research on STD/AIDS, National Institute of Infectology Evandro Chagas, FIO-CRUZ, Rio de Janeiro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Beatriz Gilda Jegerhom Grinsztejn

5Laboratory of Clinical Research on STD/AIDS, National Institute of Infectology Evandro Chagas, FIO-CRUZ, Rio de Janeiro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Valdiléa Gonçalves Veloso dos Santos

5Laboratory of Clinical Research on STD/AIDS, National Institute of Infectology Evandro Chagas, FIO-CRUZ, Rio de Janeiro

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mariza Gonçalves Morgado

1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

All data produced in the present work are contained in the manuscript

PreviousNext

Posted March 02, 2023.

Download PDF

Print/Save Options

Download PDF Full Text & In-line Figures XML

More Info

Author Declarations

Data/Code

The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients

medRxiv 2023.03.02.23286693; doi: https://doi.org/10.1101/2023.03.02.23286693

Now published in Microbiology Spectrum doi: 10.1128/spectrum.00959-23

Share This Article:

Citation Tools

Get QR code

Tweet Widget

Subject Area

Public and Global Health

Reviews and Context

Comment

TRIP Peer Reviews

Community Reviews

Automated Services

Blogs/Media

Author Videos

Subject Areas

All Articles

Addiction Medicine (423)
Allergy and Immunology (746)
Anesthesia (217)
Cardiovascular Medicine (3216)
Dentistry and Oral Medicine (355)
Dermatology (270)
Emergency Medicine (476)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1148)
Epidemiology (13229)
Forensic Medicine (19)
Gastroenterology (887)
Genetic and Genomic Medicine (5054)
Geriatric Medicine (469)
Health Economics (772)
Health Informatics (3174)
Health Policy (1126)
Health Systems and Quality Improvement (1169)
Hematology (421)
HIV/AIDS (998)
Infectious Diseases (except HIV/AIDS) (14520)
Intensive Care and Critical Care Medicine (901)
Medical Education (467)
Medical Ethics (125)
Nephrology (513)
Neurology (4795)
Nursing (253)
Nutrition (712)
Obstetrics and Gynecology (867)
Occupational and Environmental Health (780)
Oncology (2470)
Ophthalmology (700)
Orthopedics (278)
Otolaryngology (337)
Pain Medicine (319)
Palliative Medicine (89)
Pathology (528)
Pediatrics (1274)
Pharmacology and Therapeutics (542)
Primary Care Research (548)
Psychiatry and Clinical Psychology (4123)
Public and Global Health (7357)
Radiology and Imaging (1666)
Rehabilitation Medicine and Physical Therapy (988)
Respiratory Medicine (965)
Rheumatology (472)
Sexual and Reproductive Health (489)
Sports Medicine (413)
Surgery (532)
Toxicology (69)
Transplantation (229)
Urology (199)

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients

Data Availability

Subject Area

Follow this preprint